Dexrazoxane Hydrochloride and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Dexrazoxane Hydrochloride and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Hydrochloride-Insulin glulisine
- Dexrazoxane Hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Dexrazoxane Hydrochloride-Insulin Glulisine (Vials)
- Dexrazoxane Hydrochloride-Insulin glulisine Subcutaneous
- Dexrazoxane Hydrochloride-Insulin human inhaled Inhalation
- Dexrazoxane Hydrochloride-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Dexrazoxane Intravenous
- Insulin glargine, recombinant Subcutaneous-Dextenza Insert
- Insulin glargine, recombinant Subcutaneous-Dextenza intraocular
- Insulin glargine, recombinant Subcutaneous-Dextran 40
- Insulin glargine, recombinant Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin glargine, recombinant Subcutaneous-Dextran 75